Pitfalls of using polymerase chain reaction-based assays for JAK2 and CALR exon 9 variant testing in myeloproliferative neoplasms: Knowing when to go the extra mile!
Kritika KrishnamurthyJiani ChaiYanhua WangRizwan NaeemD Yitzchak GoldsteinPublished in: American journal of clinical pathology (2023)
These cases highlight the importance of understanding the pitfalls of molecular techniques in current practice.